US$ 24.04
semaglutide hfpef trial VisualAbstract: improves symptoms in patients with heart failure Semaglutide in Patients with Heart
Description
A synthetic GLP-1 receptor agonist studied for glucose regulation, insulin secretion, and metabolic function

These are different mechanisms

Type 2 diabetes mellitus (T2DM) is a complex chronic disease characterized by progressive -cell dysfunction and insulin resistance
Glucagon-like Peptide 1 (9-36) - GLP-1 Amide - CAS 161748-29-4 is diabetes peptide for research use only

Manufactured under stringent international standards by Alkem Laboratories Ltd, this advanced multi-dose disposable pen delivers a precise 1 mg dose of high-purity Semaglutide
